The Board had recommended an interim dividend of 12.5% payable to the shareholders, the record date being 10th November, 2006.
Other Highlights:
The Company has plans to expand its retail operations in the USA and discussions are in progress to acquire two stores. Once these acquisitions are complete, the revenues and profits would spurt.
Significant strides have been made in the oncology segment and the Company has reached the top slot amongst the Indian companies operating in the oncology segment.
